Net Cash Provided by (Used in) Operating Activities |
-3.34M |
USD |
-37.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-37.2K |
USD |
-20.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
4.97M |
USD |
+23.6% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
16.8M |
shares |
+6.58% |
Q2 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.59M |
USD |
+2.36% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
44.3M |
USD |
+41.9% |
Q2 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
2K |
USD |
+43% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
27.1M |
USD |
+4.58% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
27.1M |
USD |
+4.24% |
Q4 2023 |
FY 2023 |
Depreciation |
26.6K |
USD |
+41.4% |
Q1 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
14.8K |
USD |
-68.7% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-8.44M |
USD |
-39.7% |
Q2 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
321K |
USD |
-27.9% |
Q2 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-18.8K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
26.5M |
USD |
+6.63% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
+300% |
Q2 2024 |
Q1 2024 |
Additional Paid in Capital |
153M |
USD |
+2.11% |
Q2 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q1 2024 |
Amortization of Intangible Assets |
0 |
USD |
|
Q3 2023 |
Q3 2023 |
Depreciation, Depletion and Amortization |
686K |
USD |
-31.9% |
Q2 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
25.2K |
USD |
-76.6% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
395K |
USD |
+90% |
Q2 2024 |
Q1 2024 |
Interest Expense |
7.51K |
USD |
+101% |
Q2 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2024 |